{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:33:28Z","timestamp":1790105608894,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110170","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:48:10Z","timestamp":1782431290000},"page":"110170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rational design and synthesis of pyrazole-based sulfonamides as dual carbonic anhydrase and PRAK-targeting anticancer agents"],"prefix":"10.1016","volume":"180","author":[{"given":"Mariam M.","family":"Fakhry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Ziedan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ammara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalloul","family":"Bouajila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Abdelrahman","family":"Alkabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"Abou-Seri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110170_bb0005","first-page":"451","article-title":"Global cancer statistics 2022: the trends projection analysis","volume":"10","author":"Chhikara","year":"2023","journal-title":"Chem. Biol. Lett."},{"key":"10.1016\/j.bioorg.2026.110170_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110170_bb0015","series-title":"Molecular Biology of Human Cancers","first-page":"3","article-title":"An introduction to human cancers","author":"Schulz","year":"2023"},{"key":"10.1016\/j.bioorg.2026.110170_bb0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrc3486","article-title":"Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host","volume":"13","author":"Timp","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110170_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-025-02641-4","article-title":"Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies","volume":"42","author":"Shah","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bioorg.2026.110170_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-816476-1.00001-0","article-title":"Carbonic anhydrases: an overview","author":"Nocentini","year":"2019","journal-title":"Carbonic Anhydrases"},{"key":"10.1016\/j.bioorg.2026.110170_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110170_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyss\u00e9gur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110170_bb0045","doi-asserted-by":"crossref","unstructured":"W. Numprasit, S. Yangngam, J. Prasopsiri, J.A. Quinn, J. Edwards, C. Thuwajit, Carbonic anhydrase IX-related tumoral hypoxia predicts worse prognosis in breast cancer: a systematic review and meta-analysis, Front. Med., Volume 10\u20132023 (2023).","DOI":"10.3389\/fmed.2023.1087270"},{"key":"10.1016\/j.bioorg.2026.110170_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bioorg.2026.110170_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4155\/fmc-2022-0249","article-title":"Latest advances in specific inhibition of tumor-associated carbonic anhydrases","volume":"15","author":"Supuran","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2026.110170_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010134","article-title":"Synthesis and pharmacological activities of pyrazole derivatives: a review","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110170_bb0070","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2174\/1573406418666220410181827","article-title":"Pyrazole scaffolds: centrality in anti-inflammatory and antiviral drug design","volume":"18","author":"Karati","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0075","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/biomedicines10051124","article-title":"A review of the recent development in the synthesis and biological evaluations of pyrazole derivatives","volume":"10","author":"Ebenezer","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2026.110170_bb0080","first-page":"1","article-title":"A new preparation process to afuresertib, a pan-AKT inhibitor under clinical development","author":"Luo","year":"2025","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2026.110170_bb0085","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.3390\/molecules28083385","article-title":"Aurora B inhibitors as Cancer therapeutics","volume":"28","author":"Kovacs","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110170_bb0090","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1158\/0008-5472.CAN-15-3062","article-title":"Pexmetinib: a novel dual inhibitor of Tie2 and p38 MAPK with efficacy in preclinical models of myelodysplastic syndromes and acute myeloid Leukemia","volume":"76","author":"Bachegowda","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110170_bb0095","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1021\/jm2007613","article-title":"Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal\u2013Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)","volume":"54","author":"Cui","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0100","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1021\/acs.molpharmaceut.9b00274","article-title":"Avapritinib: a selective inhibitor of KIT and PDGFR\u03b1 that reverses ABCB1 and ABCG2-mediated multidrug resistance in cancer cell lines","volume":"16","author":"Wu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2026.110170_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2300696","article-title":"Pirtobrutinib after a covalent BTK inhibitor in chronic lymphocytic leukemia","volume":"389","author":"Mato","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110170_bb0110","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1021\/acs.jmedchem.0c01952","article-title":"Structural insights into JAK2 inhibition by Ruxolitinib, Fedratinib, and derivatives thereof","volume":"64","author":"Davis","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0115","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acsmedchemlett.2c00213","article-title":"Structural basis for inhibition of mutant EGFR with Lazertinib (YH25448)","volume":"13","author":"Heppner","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110170_bb0120","doi-asserted-by":"crossref","first-page":"20438","DOI":"10.1021\/acs.jmedchem.4c01894","article-title":"4-(pyrazolyl) benzenesulfonamide ureas as carbonic anhydrases inhibitors and hypoxia-mediated chemo-sensitizing agents in colorectal cancer cells","volume":"67","author":"Eldehna","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0125","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ejmech.2009.11.050","article-title":"New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity","volume":"45","author":"Riyadh","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0130","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.bmc.2017.02.037","article-title":"Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects","volume":"25","author":"Fares","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0135","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/ddr.22082","article-title":"Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease","volume":"84","author":"Ezzat","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110170_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108024","article-title":"Rational design, synthesis and computational studies of multi-targeted anti-Alzheimer's agents integrating coumarin scaffold","volume":"154","author":"Abd El-Mageed","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0145","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/00397911.2023.2209815","article-title":"Development of pyrazolo[1,5-a]pyrimidine-based antibacterial agents","volume":"53","author":"Mekky","year":"2023","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.110170_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70214","article-title":"Multitargeted anti-inflammatory agents: novel pyrazole and pyrazolo[1,5-a]pyrimidine carbonic anhydrase and COX-2 inhibitors with optimal in vivo efficacy and low toxicity","volume":"87","author":"Fakhry","year":"2026","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110170_bb0155","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/acs.jmedchem.9b02090","article-title":"Discovery of potent dual-tailed benzenesulfonamide inhibitors of human carbonic anhydrases implicated in glaucoma and in vivo profiling of their intraocular pressure-lowering action","volume":"63","author":"Fares","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0160","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110170_bb0165","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s41467-021-21993-9","article-title":"The essential role of PRAK in tumor metastasis and its therapeutic potential","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110170_bb0170","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1158\/1535-7163.MCT-21-0958","article-title":"YES1: a novel therapeutic target and biomarker in Cancer","volume":"21","author":"Garmendia","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2026.110170_bb0175","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/ijms25031450","article-title":"Emerging roles of YES1 in cancer: the putative target in drug resistance","volume":"25","author":"Kook","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110170_bb0180","doi-asserted-by":"crossref","unstructured":"X. Wang, L. Kokabee, M. Kokabee, D.S. Conklin, Bruton's tyrosine kinase and its isoforms in cancer, Front. Cell Dev. Biol., Volume 9\u20132021 (2021).","DOI":"10.3389\/fcell.2021.668996"},{"key":"10.1016\/j.bioorg.2026.110170_bb0185","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s12276-025-01544-8","article-title":"MAP4K signaling pathways in cancer: roles, mechanisms and therapeutic opportunities","volume":"57","author":"Bunardi","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bioorg.2026.110170_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2026.110170_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107766","article-title":"Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction","volume":"153","author":"Elgohary","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0200","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0205","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.110170_bb0210","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/14756366.2022.2053526","article-title":"The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII","volume":"37","author":"Bonardi","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0215","unstructured":"C. The UniProt, UniProt: the universal protein knowledgebase in 2025, Nucleic Acids Res., 53 (2025) D609-D617."},{"key":"10.1016\/j.bioorg.2026.110170_bb0220","series-title":"Open Access Databases and Datasets for Drug Discovery","first-page":"175","article-title":"The SWISS-MODEL Repository of 3D Protein Structures and Models","author":"Robin","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110170_bb0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00018-010-0452-1","article-title":"The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5\/PRAK) inhibitor","volume":"68","author":"Kostenko","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2026.110170_bb0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2026.110170_bb0235","first-page":"3","article-title":"Crystal structure refinement with SHELXL, crystal structure","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Communications"},{"key":"10.1016\/j.bioorg.2026.110170_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122537","article-title":"Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors","volume":"631","author":"Eldehna","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2026.110170_bb0245","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2026.110170_bb0250","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110170_bb0255","series-title":"S. Schr\u00f6dinger Suite Release 2024-3, LLC, New York, NY","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110170_bb0260","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.110170_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117620","article-title":"Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococci","volume":"291","author":"Ammara","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0270","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1021\/acs.jmedchem.4c01866","article-title":"Enhanced recognition memory through dual modulation of brain carbonic anhydrases and Cholinesterases","volume":"67","author":"Nocentini","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0275","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110170_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:46:12Z","timestamp":1787676372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"alternative-id":["S0045206826007066"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110170","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design and synthesis of pyrazole-based sulfonamides as dual carbonic anhydrase and PRAK-targeting anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110170"}}